Literature DB >> 20638385

Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis.

Ting-Kuang Niu1, Yan Cheng, Xingcong Ren, Jin-Ming Yang.   

Abstract

We reported a novel interaction between Beclin 1, a key regulator of autophagy, and survivin, a member of the inhibitor of apoptosis protein family. We found that knock-down of Beclin 1 down-regulated survivin protein, and the turnover rate of survivin was increased when Beclin 1 expression was silenced. Knock-down of Beclin 1 sensitized glioma cells to TRAIL-induced apoptosis, and introduction of survivin antagonized the sensitizing effect, suggesting that down-regulation of survivin mediates the enhanced sensitivity to TRAIL-induced apoptosis. These results demonstrate a novel interaction between Beclin 1 and survivin, and may provide a potential mechanism underlying the cross-talk between autophagy and apoptosis. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638385      PMCID: PMC3210451          DOI: 10.1016/j.febslet.2010.07.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG.

Authors:  Chengyu Liang; Pinghui Feng; Bonsu Ku; Iris Dotan; Dan Canaani; Byung-Ha Oh; Jae U Jung
Journal:  Nat Cell Biol       Date:  2006-06-25       Impact factor: 28.824

3.  Differential interactions between Beclin 1 and Bcl-2 family members.

Authors:  Shlomit Erlich; Liat Mizrachy; Oshik Segev; Liora Lindenboim; Ofir Zmira; Sheli Adi-Harel; Joel A Hirsch; Reuven Stein; Ronit Pinkas-Kramarski
Journal:  Autophagy       Date:  2007-07-08       Impact factor: 16.016

Review 4.  IAP family proteins--suppressors of apoptosis.

Authors:  Q L Deveraux; J C Reed
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

Review 5.  The role of apoptosis in cancer development and treatment response.

Authors:  J Martin Brown; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

6.  mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.

Authors:  Amith Panner; C David James; Mitchel S Berger; Russell O Pieper
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 7.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  Endogenous tumor suppression mediated by PTEN involves survivin gene silencing.

Authors:  Minakshi Guha; Janet Plescia; Irwin Leav; Jing Li; Lucia R Languino; Dario C Altieri
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

9.  Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

Authors:  Simone Fulda; Wolfgang Wick; Michael Weller; Klaus-Michael Debatin
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

10.  The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner.

Authors:  J Zhao; T Tenev; L M Martins; J Downward; N R Lemoine
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  33 in total

Review 1.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

Review 2.  Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?

Authors:  Lisa Gherardini; Giuseppe Bardi; Mariangela Gennaro; Tommaso Pizzorusso
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

Review 3.  Targeting autophagy in breast cancer.

Authors:  Paola Maycotte; Andrew Thorburn
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Autophagy as a mechanism of Apo2L/TRAIL resistance.

Authors:  Arishya Sharma; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

5.  Cross-talk between apoptosis and autophagy in lung epithelial cell death.

Authors:  Jincheng Yang; Hyung-Geun Moon; Sukrutha Chettimada; Yang Jin
Journal:  J Biochem Pharmacol Res       Date:  2014-04-05

Review 6.  Autophagy-Dependent Ferroptosis: Machinery and Regulation.

Authors:  Jiao Liu; Feimei Kuang; Guido Kroemer; Daniel J Klionsky; Rui Kang; Daolin Tang
Journal:  Cell Chem Biol       Date:  2020-03-10       Impact factor: 8.116

7.  BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.

Authors:  J Hagenbuchner; U Kiechl-Kohlendorfer; P Obexer; M J Ausserlechner
Journal:  Oncogene       Date:  2015-07-06       Impact factor: 9.867

Review 8.  Combined modality therapy with TRAIL or agonistic death receptor antibodies.

Authors:  Hope M Amm; Patsy G Oliver; Choo Hyung Lee; Yufeng Li; Donald J Buchsbaum
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

Review 9.  The Beclin 1 network regulates autophagy and apoptosis.

Authors:  R Kang; H J Zeh; M T Lotze; D Tang
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

10.  Beclin-1 knockdown shows abscission failure but not autophagy defect during oocyte meiotic maturation.

Authors:  Seung Yeop You; Yong Seok Park; Hyuk-Joon Jeon; Dong-Hyung Cho; Hong Bae Jeon; Sung Hyun Kim; Jong Wook Chang; Jae-Sung Kim; Jeong Su Oh
Journal:  Cell Cycle       Date:  2016-05-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.